{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:58:37Z","timestamp":1790362717450,"version":"4.1.0"},"reference-count":152,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,1,22]]},"abstract":"<jats:p>Retinoids, which are vitamin A derivatives, interact through retinoic acid receptors (RARs) and retinoid X receptors (RXRs) and have profound effects on several physiological and pathological processes in the brain. The presence of retinoic acid signaling is extensively detected in the adult central nervous system, including the amygdala, cortex, hypothalamus, hippocampus, and other brain areas. Retinoids are primarily involved in neural patterning, differentiation, and axon outgrowth. Retinoids also play a key role in the preservation of the differentiated state of adult neurons. Impairment in retinoic acid signaling can result in neurodegeneration and progression of Alzheimer\u2019s disease (AD). Recent studies demonstrated severe deficiencies in spatial learning and memory in mice during retinoic acid (vitamin A) deprivation indicating its significance in preserving memory function. Defective cholinergic neurotransmission plays an important role in cognitive deficits in AD. All-trans retinoic acid is known to enhance the expression and activity of choline acetyltransferase in neuronal cell lines. Activation of RAR and RXR is also known to impede the pathogenesis of AD in mice by inhibiting accumulation of amyloids. In addition, retinoids have been shown to inhibit the expression of chemokines and pro-inflammatory cytokines in microglia and astrocytes, which are activated in AD. In this review article, we have described the chemistry and molecular signaling mechanisms of natural and synthetic retinoids and current understandings of their therapeutic potentials in prevention of AD pathology.<\/jats:p>","DOI":"10.3233\/jad-150450","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T09:25:52Z","timestamp":1453454752000},"page":"335-352","source":"Crossref","is-referenced-by-count":53,"title":["Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"50","author":[{"given":"Mrinmay","family":"Chakrabarti","sequence":"first","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Will Reed","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, University of South Carolina, Columbia, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Moss","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, University of South Carolina, Columbia, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar C.","family":"Das","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapan K.","family":"Ray","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine, Columbia, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-150450_ref1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer\u2019s disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"10.3233\/JAD-150450_ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7015-7-7","article-title":"Recent developments in Alzheimer\u2019s disease therapeutics","volume":"7","author":"Rafii","year":"2009","journal-title":"BMC Med"},{"key":"10.3233\/JAD-150450_ref3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.3233\/JAD-150450_ref4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","article-title":"Neuropathology and biochemistry of A\u03b2 and its aggregates in Alzheimer\u2019s disease","volume":"129","author":"Thal","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-150450_ref5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.genom.3.022502.103022","article-title":"Deciphering the genetic basis of Alzheimer\u2019s disease","volume":"3","author":"Selkoe","year":"2002","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.3233\/JAD-150450_ref6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.3233\/JAD-150450_ref7","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1017\/S1041610212000579","article-title":"Current insights into the pathophysiology of Alzheimer\u2019s disease: Selecting targets for early therapeutic intervention","volume":"24","author":"Hampel","year":"2012","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-150450_ref8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease - a double-edged sword","volume":"35","author":"Wyss-Coray","year":"2002","journal-title":"Neuron"},{"key":"10.3233\/JAD-150450_ref9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150450_ref10","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer\u2019s disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-150450_ref11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2741\/e368","article-title":"Peripheral cholesterol, metabolic disorders and Alzheimer\u2019s disease","volume":"4","author":"Ledesma","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.3233\/JAD-150450_ref12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-150450_ref13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","article-title":"Cerebrovascular effects of apolipoprotein E: Implications for Alzheimer\u2019s disease","volume":"70","author":"Zlokovic","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-150450_ref14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/biof.196","article-title":"Retinoids for treatment of Alzheimer\u2019s disease","volume":"38","author":"Lerner","year":"2012","journal-title":"Biofactors"},{"key":"10.3233\/JAD-150450_ref15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jcp.20784","article-title":"Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer\u2019s disease","volume":"209","author":"Goodman","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.3233\/JAD-150450_ref16","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1073\/pnas.0437937100","article-title":"Evidence for defective retinoid transport and function in late onset Alzheimer\u2019s disease","volume":"100","author":"Goodman","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150450_ref17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/156720509788486581","article-title":"Towards retinoid therapy for Alzheimer\u2019s disease","volume":"6","author":"Shudo","year":"2009","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-150450_ref18","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1586\/ern.09.86","article-title":"All-trans retinoic acid as a novel therapeutic strategy for Alzheimer\u2019s disease","volume":"9","author":"Lee","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.3233\/JAD-150450_ref19","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/ejn.12142","article-title":"Amyloid \u03b2 inhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptor \u03b1 agonist","volume":"37","author":"Goncalves","year":"2013","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-150450_ref20","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","article-title":"Cholinergic system during the progression of Alzheimer\u2019s disease: Therapeutic implications","volume":"8","author":"Mufson","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"10.3233\/JAD-150450_ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150450_ref22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/ar050069h","article-title":"Kinetics and thermodynamics of amyloid fibril assembly","volume":"39","author":"Wetzel","year":"2006","journal-title":"Acc Chem Res"},{"key":"10.3233\/JAD-150450_ref23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1073\/pnas.0406847102","article-title":"Molecular basis for amyloid fibril formation and stability","volume":"102","author":"Makin","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150450_ref24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.sbi.2007.01.007","article-title":"Polymorphism in the intermediates and products of amyloid assembly","volume":"17","author":"Kodali","year":"2007","journal-title":"Curr Opin Struct Biol"},{"key":"10.3233\/JAD-150450_ref25","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A\u03b2 oligomers - A decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-150450_ref26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/cn300050d","article-title":"Familial Alzheimer\u2019s disease mutations differentially alter amyloid \u03b2- protein oligomerization","volume":"3","author":"Gessel","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-150450_ref27","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","article-title":"Amyloid \u03b2-protein fibrillogenesis: Detection of a protofibrillar intermediate","volume":"272","author":"Walsh","year":"1997","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-150450_ref28","doi-asserted-by":"crossref","first-page":"19232","DOI":"10.1073\/pnas.0703793104","article-title":"Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing A\u03b2 protofibrils","volume":"104","author":"Habicht","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150450_ref29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.3233\/JAD-150450_ref30","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1021\/bi802046n","article-title":"Structural characterization of a soluble amyloid \u03b2-peptide oligomer","volume":"48","author":"Yu","year":"2009","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-150450_ref31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuropharm.2010.07.012","article-title":"ADDLs and the signaling web that leads to Alzheimer\u2019s disease","volume":"59","author":"Krafft","year":"2010","journal-title":"Neuropharmacol"},{"key":"10.3233\/JAD-150450_ref32","doi-asserted-by":"crossref","first-page":"21253","DOI":"10.1074\/jbc.M112.355156","article-title":"Specific soluble oligomers of amyloid-beta peptide undergo replication and form non-fibrillar aggregates in interfacial environments","volume":"287","author":"Kumar","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-150450_ref33","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/j.neurobiolaging.2011.12.032","article-title":"Dispersible amyloid \u03b2-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: Their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice","volume":"33","author":"Rijal Upadhaya","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150450_ref34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/brain\/awt362","article-title":"Biochemical stages of amyloid \u03b2-peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer\u2019s disease","volume":"137","author":"Rijal Upadhaya","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-150450_ref35","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/nu6031209","article-title":"Vitamin A\/retinol and maintenance of pluripotency of stem cells","volume":"6","author":"Khillan","year":"2014","journal-title":"Nutrients"},{"key":"10.3233\/JAD-150450_ref36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02760863","article-title":"Properties of retinoids. Structure, handling, and preparation","volume":"10","author":"Barua","year":"1998","journal-title":"Mol Biotechnol"},{"key":"10.3233\/JAD-150450_ref37","doi-asserted-by":"crossref","first-page":"281S","DOI":"10.1093\/jn\/134.1.281S","article-title":"Analysis of retinoids and carotenoids: Problems resolved and unsolved","volume":"134","author":"Furr","year":"2004","journal-title":"J Nutr"},{"key":"10.3233\/JAD-150450_ref38","first-page":"270","article-title":"The Wittig reaction","volume":"14","author":"Maercker","year":"1965","journal-title":"Org React"},{"key":"10.3233\/JAD-150450_ref39","first-page":"746","article-title":"Use of sulfones in synthesis. III. Synthesis of vitamin A","author":"Julia","year":"1973","journal-title":"Bull Soc Chim Fr"},{"key":"10.3233\/JAD-150450_ref40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1751-1097.1997.tb01896.x","article-title":"Steric hindrance between chromophore substituents as the driving force of rhodopsin isomerization: 10-methyl-13-demethyl retinal containing rhodopsin","volume":"65","author":"Koch","year":"1997","journal-title":"Photochem Photobiol"},{"key":"10.3233\/JAD-150450_ref41","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrd2397","article-title":"RAR and RXR modulation in cancer and metabolic disease","volume":"6","author":"Altucci","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-150450_ref42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/156802612799436687","article-title":"Retinoid receptors and therapeutic applications of RAR\/RXR modulators","volume":"12","author":"le Maire","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.3233\/JAD-150450_ref43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bmc.2013.11.025","article-title":"Retinoic acid signaling pathways in development and diseases","volume":"22","author":"Das","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.3233\/JAD-150450_ref44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0003-9861(85)90248-6","article-title":"The growth supporting activity of a retinoidal benzoic acid derivative and 4,4-difluororetinoic acid","volume":"237","author":"Stephens-Jarnagin","year":"1985","journal-title":"ArchBiochem Biophys"},{"key":"10.3233\/JAD-150450_ref45","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1021\/jm0581821","article-title":"Synthetic retinoids: Recent developments concerning structure and clinical utility","volume":"48","author":"Kagechika","year":"2005","journal-title":"J Med Chem"},{"key":"10.3233\/JAD-150450_ref46","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nchembio.1230","article-title":"Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives","volume":"9","author":"Anguiano","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.3233\/JAD-150450_ref47","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1460-9568.2004.03563.x","article-title":"Disruption of the retinoid signalling pathway causes a deposition of amyloid \u03b2 in the adult rat brain","volume":"20","author":"Corcoran","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-150450_ref48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2006.01.008","article-title":"Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in beta-amyloid deposits in the cerebral cortex of vitamin A deprived rats","volume":"23","author":"Husson","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-150450_ref49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0022-510X(87)90156-0","article-title":"Immunodetection of protein composition in cerebral amyloid extracts in Alzheimer\u2019s disease: Enrichment of retinol-binding protein","volume":"80","author":"Maury","year":"1987","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-150450_ref50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0169-328X(95)00078-7","article-title":"Promoter activity of the gene encoding the \u03b2-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1","volume":"32","author":"Lahiri","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"10.3233\/JAD-150450_ref51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0169-328X(98)00164-8","article-title":"Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species","volume":"60","author":"Yang","year":"1998","journal-title":"Mol Brain Res"},{"key":"10.3233\/JAD-150450_ref52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000095264","article-title":"\u03b1-secretase activation - an approach to Alzheimer\u2019s disease therapy","volume":"3","author":"Fahrenholz","year":"2006","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-150450_ref53","first-page":"289","article-title":"Amyloid precursor protein beta -secretase (BACE) mRNA expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines and growth factors","volume":"20","author":"Satoh","year":"2000","journal-title":"Neuropathology"},{"key":"10.3233\/JAD-150450_ref54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/359064a0","article-title":"Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor","volume":"359","author":"Yoshikawa","year":"1992","journal-title":"Nature"},{"key":"10.3233\/JAD-150450_ref55","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.expneurol.2004.05.035","article-title":"Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro","volume":"189","author":"Ono","year":"2004","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-150450_ref56","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer\u2019s disease and senile dementia: Loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.3233\/JAD-150450_ref57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF03036453","article-title":"Retinoic acid isomers protect hippocampal neurons from amyloid-\u03b2 induced neurodegeneration","volume":"7","author":"Sahin","year":"2005","journal-title":"Neurotox Res"},{"key":"10.3233\/JAD-150450_ref58","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1074\/jbc.271.8.4410","article-title":"Regulation of acetylcholinesterase expression during neuronal differentiation","volume":"271","author":"Coleman","year":"1996","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-150450_ref59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-3806(97)00076-X","article-title":"Characterisation of the colinergic neuronal differentiation of the human neuroblastoma cell line LAN-5 after treatment with retinoic acid","volume":"102","author":"Hill","year":"1997","journal-title":"Dev Brain Res"},{"key":"10.3233\/JAD-150450_ref60","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1242\/dev.125.7.1173","article-title":"Defined concentrations of a posteriorizing signal are critical for MafB\/Kreisler segmental expression in the hindbrain","volume":"125","author":"Grapin-Botton","year":"1998","journal-title":"Development"},{"key":"10.3233\/JAD-150450_ref61","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neuint.2011.04.004","article-title":"Carotenoids and Alzheimer\u2019s disease: An insight into therapeutic role of retinoids in animal models","volume":"59","author":"Obulesu","year":"2011","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-150450_ref62","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrn2212","article-title":"Retinoic acid in the development, regeneration and maintenance of the nervous system","volume":"8","author":"Maden","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-150450_ref63","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2353\/ajpath.2008.080175","article-title":"Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer\u2019s disease","volume":"173","author":"Paulson","year":"2008","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-150450_ref64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-2011-110455","article-title":"Vitamin A has anti-oligomerization effects on amyloid-\u03b2 in vitro","volume":"27","author":"Takasaki","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150450_ref65","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1460-9568.2010.07426.x","article-title":"Retinoic acid receptor-\u03b1 signalling antagonizes both intracellular and extracellular amyloid-\u03b2 production and prevents neuronal cell death caused by amyloid-\u03b2","volume":"32","author":"Jarvis","year":"2010","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-150450_ref66","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1523\/JNEUROSCI.3153-08.2008","article-title":"Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer\u2019s disease transgenic mouse model","volume":"28","author":"Ding","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150450_ref67","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1111\/j.1742-4658.2009.06992.x","article-title":"Regulation of secretases by all-trans-retinoic acid","volume":"276","author":"Koryakina","year":"2009","journal-title":"FEBS J"},{"key":"10.3233\/JAD-150450_ref68","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1248\/bpb.b12-00314","article-title":"Tamibarotene: A candidate retinoid drug for Alzheimer\u2019s disease","volume":"35","author":"Fukasawa","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.3233\/JAD-150450_ref69","first-page":"787","article-title":"Regulation by retinoic acid of insulin-degrading enzyme and of a related endoprotease in human neuroblastoma cell lines","volume":"7","author":"Melino","year":"1996","journal-title":"Cell Growth Differ"},{"key":"10.3233\/JAD-150450_ref70","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrd3869","article-title":"Drug repositioning for Alzheimer\u2019s disease","volume":"11","author":"Corbett","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-150450_ref71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","article-title":"A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis","volume":"7","author":"Chawla","year":"2001","journal-title":"Mol Cell"},{"key":"10.3233\/JAD-150450_ref72","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14728222.2011.594043","article-title":"Nuclear receptors as therapeutic targets for Alzheimer\u2019s disease","volume":"15","author":"Mandrekar-Colucci","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"10.3233\/JAD-150450_ref73","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1200\/JCO.2003.05.068","article-title":"Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer","volume":"21","author":"Esteva","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3233\/JAD-150450_ref74","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1158\/1078-0432.CCR-06-1836","article-title":"A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer","volume":"13","author":"Dragnev","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.3233\/JAD-150450_ref75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/NDT.S61309","article-title":"The emerging role of bexarotene in the treatment of Alzheimer\u2019s disease: Current evidence","volume":"11","author":"Tousi","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.3233\/JAD-150450_ref76","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science"},{"key":"10.3233\/JAD-150450_ref77","doi-asserted-by":"crossref","first-page":"924-c","DOI":"10.1126\/science.1235809","article-title":"Comment on \u201cApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models\u201d","volume":"340","author":"Fitz","year":"2013","journal-title":"Science"},{"key":"10.3233\/JAD-150450_ref78","doi-asserted-by":"crossref","first-page":"924-d","DOI":"10.1126\/science.1234089","article-title":"Felsenstein KM. Comment on \u201cApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models\u201d.","volume":"340","author":"Price","year":"2013","journal-title":"Science"},{"key":"10.3233\/JAD-150450_ref79","doi-asserted-by":"crossref","first-page":"924-f","DOI":"10.1126\/science.1235505","article-title":"Comment on\u201cApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models\u201d.","volume":"340","author":"Veeraraghavalu","year":"2013","journal-title":"Science"},{"key":"10.3233\/JAD-150450_ref80","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.NT.0000452276.24201.20","article-title":"News from the ANN annual meeting: RXR agonist shows potential for myelin repair in vitro, new study suggests","volume":"14","author":"Collins","year":"2014","journal-title":"Neurology Today"},{"key":"10.3233\/JAD-150450_ref81","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1042\/BST0390886","article-title":"Assessing the contribution of inflammation in models of Alzheimer\u2019s disease","volume":"39","author":"Johnston","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-150450_ref82","first-page":"314185","article-title":"Microglia in Alzheimer\u2019s disease: It\u2019s all about context","volume":"2012","author":"Weitz","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-150450_ref83","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2005-7304","article-title":"Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer\u2019s disease patients","volume":"7","author":"Fiala","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150450_ref84","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/1568010042634587","article-title":"Retinoid receptors in inflammatory responses: A potential target for pharmacology","volume":"3","author":"Kuenzli","year":"2004","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.3233\/JAD-150450_ref85","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4049\/jimmunol.152.3.1419","article-title":"Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts","volume":"152","author":"Zitnik","year":"1994","journal-title":"J\u00a0Immunol"},{"key":"10.3233\/JAD-150450_ref86","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/bbrc.1997.6087","article-title":"Inhibition of IL-1-induced IL-6 production by synthetic retinoids","volume":"231","author":"Kagechika","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-150450_ref87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/glia.20153","article-title":"Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia","volume":"50","author":"Dheen","year":"2005","journal-title":"Glia"},{"key":"10.3233\/JAD-150450_ref88","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.neuroscience.2005.12.025","article-title":"Insulin-like growth factor I and II expression and modulation in amoeboid microglial cells by lipopolysaccharide and retinoic acid","volume":"138","author":"Kaur","year":"2006","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-150450_ref89","first-page":"6119","article-title":"Are retinoids a promise for Alzheimer\u2019s disease management?","volume":"19","author":"Carrat\u00fa","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.3233\/JAD-150450_ref90","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1471-4159.2009.06171.x","article-title":"Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling","volume":"110","author":"Katsuki","year":"2009","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-150450_ref91","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1471-4159.2008.05395.x","article-title":"Anti-inflammatory effect of retinoic acid on prostaglandin synthesis in cultured cortical astrocytes","volume":"106","author":"Kampmann","year":"2008","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-150450_ref92","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1046\/j.1471-4159.1998.71052034.x","article-title":"Increased nuclear DNA oxidation in the brain in Alzheimer\u2019s disease","volume":"71","author":"Gabbita","year":"1998","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-150450_ref93","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","article-title":"RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer\u2019s disease","volume":"19","author":"Nunomura","year":"1999","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150450_ref94","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-150450_ref95","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1073\/pnas.91.23.10771","article-title":"Oxidative damage and mitochondrial decay in aging","volume":"91","author":"Shigenaga","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150450_ref96","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nbdi.2002.0515","article-title":"Oxidative stress increases expression and activity of BACE in NT2 neurons","volume":"10","author":"Tamagno","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-150450_ref97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(97)00536-3","article-title":"Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells","volume":"231","author":"Gasparini","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-150450_ref98","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s007020050098","article-title":"The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells","volume":"105","author":"Webster","year":"1998","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-150450_ref99","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A\u03b2 accumulation in Alzheimer\u2019s disease neurons: Implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-150450_ref100","doi-asserted-by":"crossref","first-page":"10480","DOI":"10.1523\/JNEUROSCI.3231-06.2006","article-title":"Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons","volume":"26","author":"Rui","year":"2006","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150450_ref101","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1471-4159.2011.07581.x","article-title":"Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"120","author":"Sheng","year":"2012","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-150450_ref102","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1073\/pnas.83.8.2758","article-title":"Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors","volume":"83","author":"Peterson","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150450_ref103","first-page":"459","article-title":"Mitochondrial abnormalities in cortical dendrites from patients with Alzheimer\u2019s disease","volume":"17","author":"Saraiva","year":"1985","journal-title":"J Submicrosc Cytol"},{"key":"10.3233\/JAD-150450_ref104","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneur.1988.00520320022009","article-title":"Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer\u2019s disease","volume":"45","author":"Gibson","year":"1988","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150450_ref105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/JAD-2002-4312","article-title":"The role of the metabolic lesion in Alzheimer\u2019s disease","volume":"4","author":"Blass","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150450_ref106","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","article-title":"Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis","volume":"21","author":"Pratic\u00f2","year":"2001","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150450_ref107","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.jnen.0000228136.58062.bf","article-title":"Involvement of oxidative stress in Alzheimer disease","volume":"65","author":"Nunomura","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-150450_ref108","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/1097-4547(20000615)60:6<767::AID-JNR9>3.0.CO;2-6","article-title":"Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression","volume":"60","author":"Ahlemeyer","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-150450_ref109","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0891-5849(01)00495-6","article-title":"Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level","volume":"30","author":"Ahlemeyer","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-150450_ref110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/scientificamerican1200-76","article-title":"Piecing together Alzheimer\u2019s disease","volume":"283","author":"St George-Hyslop","year":"2000","journal-title":"Sci Am"},{"key":"10.3233\/JAD-150450_ref111","first-page":"7","article-title":"Neuropathologic changes in Alzheimer\u2019s disease","volume":"64","author":"Wenk","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.3233\/JAD-150450_ref112","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer\u2019s disease. translating basic science into clinical care","volume":"37","author":"Trillo","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-150450_ref113","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0031-9384(03)00219-1","article-title":"Age-related sex differences in spatial learning and basal forebrain cholinergic neurons in F344 rats","volume":"80","author":"Veng","year":"2003","journal-title":"Physiol Behav"},{"key":"10.3233\/JAD-150450_ref114","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neurobiolaging.2003.10.010","article-title":"Behavioral and neurobiological markers of Alzheimer\u2019s disease in Ts65Dn mice: Effects of estrogen","volume":"25","author":"Hunter","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150450_ref115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF00634455","article-title":"Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats","volume":"99","author":"Santucci","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-150450_ref116","doi-asserted-by":"crossref","first-page":"22101","DOI":"10.1074\/jbc.270.38.22101","article-title":"Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor alpha, cAMP, and leukemia inhibitory factor\/ciliary neurotrophic factor signaling pathways in a murine septal cell line","volume":"270","author":"Berse","year":"1995","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-150450_ref117","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-5793(94)80204-1","article-title":"Cholinergic differentiation of cultured sympathetic neurons induced by retinoic acid. Induction of choline acetyltransferase-mRNA and suppression of tyrosine hydroxylase-mRNA levels","volume":"337","author":"Kobayashi","year":"1994","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-150450_ref118","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1471-4159.1995.65010050.x","article-title":"All-trans- and 9-cis-retinoic acid enhance the cholinergic properties of a murine septal cell line: Evidence that the effects are mediated by activation of retinoic acid receptor-alpha","volume":"65","author":"Pedersen","year":"1995","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-150450_ref119","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1192\/bjp.136.6.533","article-title":"Changes in the monoamine containing neurones of the human CNS in senile dementia","volume":"136","author":"Mann","year":"1980","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-150450_ref120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(83)90171-4","article-title":"Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer\u2019s type","volume":"39","author":"Iversen","year":"1983","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-150450_ref121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-510X(88)90179-7","article-title":"A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer\u2019s disease","volume":"84","author":"Reinikainen","year":"1988","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-150450_ref122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","article-title":"Monoaminergic neurotransmitters,their precursors and metabolites in brains of Alzheimer patients","volume":"203","author":"Storga","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-150450_ref123","first-page":"51","article-title":"Biogenic amines in cerebrospinal fluid and plasma of patients with dementia of Alzheimer\u2019s type","volume":"2","author":"Pinessi","year":"1987","journal-title":"Funct Neurol"},{"key":"10.3233\/JAD-150450_ref124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(84)90341-0","article-title":"Striatal dopamine receptors in Alzheimer-type dementia","volume":"52","author":"Cross","year":"1984","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-150450_ref125","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1212\/WNL.47.4.1065","article-title":"Reduced striatal dopamine receptors in Alzheimer\u2019s disease: Single photon emission tomography study with the D2 tracer [123I]-IBZM","volume":"47","author":"Pizzolato","year":"1996","journal-title":"Neurology"},{"key":"10.3233\/JAD-150450_ref126","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1212\/WNL.55.2.205","article-title":"PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD","volume":"55","author":"Kemppainen","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-150450_ref127","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1471-4159.2001.00044.x","article-title":"Regulation of the tyrosine hydroxylase and dopamine beta-hydroxylase genes by the transcription factor AP-2","volume":"76","author":"Kim","year":"2001","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-150450_ref128","doi-asserted-by":"crossref","first-page":"14349","DOI":"10.1073\/pnas.94.26.14349","article-title":"Regu1lation of dopaminergic pathways by retinoids: Activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family","volume":"94","author":"Samad","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150450_ref129","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1111\/j.1460-9568.2004.03744.x","article-title":"Post-training intrabasolateral amygdala infusions of dopamine modulate consolidation of inhibitory avoidance memory: Involvement of noradrenergic and cholinergic systems","volume":"20","author":"Lalumiere","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-150450_ref130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.27.070203.144157","article-title":"The amygdala modulates the consolidation of memories of emotionally arousing experiences","volume":"27","author":"McGaugh","year":"2004","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JAD-150450_ref131","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/neu.20248","article-title":"Retinoids and spinal cord development","volume":"66","author":"Maden","year":"2006","journal-title":"J Neurobiol"},{"key":"10.3233\/JAD-150450_ref132","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0092-8674(78)90008-9","article-title":"The induction of differentiation in teratocarcinoma stem cells by retinoic acid","volume":"15","author":"Strickland","year":"1978","journal-title":"Cell"},{"key":"10.3233\/JAD-150450_ref133","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nn1622","article-title":"Retinoic acid receptor beta2 promotes functional regeneration of sensory axons in the spinal cord","volume":"9","author":"Wong","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-150450_ref134","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1242\/jcs.00046","article-title":"Retinoic acid receptor beta2 and neurite outgrowth in the adult mouse spinal cord in vitro","volume":"115","author":"Corcoran","year":"2002","journal-title":"J Cell Sci"},{"key":"10.3233\/JAD-150450_ref135","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1358\/dot.2007.43.8.1072615","article-title":"Tamibarotene","volume":"43","author":"Miwako","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"10.3233\/JAD-150450_ref136","first-page":"40","article-title":"Basicbiology and therapeutic application of stem cells in various human and animal diseases","volume":"4","author":"Dubie","year":"2014","journal-title":"J Cell Biol Genet"},{"key":"10.3233\/JAD-150450_ref137","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/org.3.1.3961","article-title":"Application of regenerative medicine for kidney diseases","volume":"3","author":"Yokoo","year":"2007","journal-title":"Organogenesis"},{"key":"10.3233\/JAD-150450_ref138","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1039\/b808574a","article-title":"Synthesis and evaluation of synthetic retinoid derivatives as inducers of stem cell differentiation","volume":"6","author":"Christie","year":"2008","journal-title":"Org Biomol Chem"},{"key":"10.3233\/JAD-150450_ref139","first-page":"250","article-title":"Regenerative therapy for retinal disorders","volume":"5","author":"Daftarian","year":"2010","journal-title":"J Ophthalmic Vis Res"},{"key":"10.3233\/JAD-150450_ref140","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jcp.22417","article-title":"Retinoids regulate stem cell differentiation","volume":"226","author":"Gudas","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.3233\/JAD-150450_ref141","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/scrt73","article-title":"The role of induced pluripotent stem cells in regenerative medicine: Neurodegenerative diseases","volume":"2","author":"Peng","year":"2011","journal-title":"Stem Cell Res Ther"},{"key":"10.3233\/JAD-150450_ref142","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/jid.2011.2","article-title":"Regenerative medicine for skin diseases: IPS cells to the rescue","volume":"131","author":"Uitto","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.3233\/JAD-150450_ref143","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(12)60075-0","article-title":"Towards regenerative therapy for cardiac disease","volume":"379","author":"Ptaszek","year":"2012","journal-title":"Lancet"},{"key":"10.3233\/JAD-150450_ref144","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/stem.479","article-title":"Retinoic acid synthesis promotes development of neural progenitors from mouse embryonic stem cells by suppressing endogenous, Wnt-dependent nodal signaling","volume":"28","author":"Engberg","year":"2010","journal-title":"Stem Cells"},{"key":"10.3233\/JAD-150450_ref145","doi-asserted-by":"crossref","first-page":"e27945","DOI":"10.1371\/journal.pone.0027945","article-title":"Novel retinoic acid receptor \u03b1 agonists for treatment of kidney disease","volume":"6","author":"Zhong","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-150450_ref146","first-page":"CD006378","article-title":"Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer\u2019s disease","volume":"2","author":"Jaturapatporn","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-150450_ref147","doi-asserted-by":"crossref","first-page":"e20153","DOI":"10.1371\/journal.pone.0020153","article-title":"Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)(SL) mice","volume":"6","author":"Lull","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-150450_ref148","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/hmg\/dds128","article-title":"Mitochondria-targeted catalase reduces abnormal APP processing, amyloid beta production and BACE1 in a mouse model of Alzheimer\u2019s disease: Implications for neuroprotection and lifespan extension","volume":"21","author":"Mao","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-150450_ref149","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.arr.2012.09.002","article-title":"Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer\u2019s disease","volume":"12","author":"Li","year":"2013","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-150450_ref150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/scitranslmed.3003771","article-title":"A human stem cell model of early Alzheimer\u2019s disease pathology in Down syndrome","volume":"4","author":"Shi","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-150450_ref151","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/15680266113139990135","article-title":"The multifactorial nature of Alzheimer\u2019s disease for developing potential therapeutics","volume":"13","author":"Carreiras","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.3233\/JAD-150450_ref152","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1570159X1203140511153200","article-title":"Multi-target directed drugs: A modern approach for design of new drugs for treatment of Alzheimer\u2019s disease","volume":"12","author":"Dias","year":"2014","journal-title":"Curr Neuropharmacol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-150450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:01:56Z","timestamp":1777370516000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-150450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":152,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-150450","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]}}}